These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29186419)

  • 1. Management of ventricular tachycardia in the ablation era: results of the European Heart Rhythm Association Survey.
    Tilz RR; Lenarczyk R; Scherr D; Haugaa KH; Iliodromitis K; Pürerfellner H; Kiliszek M; Dagres N
    Europace; 2018 Jan; 20(1):209-213. PubMed ID: 29186419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of patients with ventricular tachycardia in Europe: results of the European Heart Rhythm Association survey.
    Chen J; Todd DM; Proclemer A; Sciaraffia E; Estner HL; Broadhurst P; Blomström-Lundqvist C; ;
    Europace; 2015 Aug; 17(8):1294-9. PubMed ID: 26273104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current practice in Europe: how do we manage patients with ventricular tachycardia? European Heart Rhythm Association survey.
    Proclemer A; Dagres N; Marinskis G; Pison L; Lip GY; Blomstrom-Lundqvist C;
    Europace; 2013 Feb; 15(2):167-9. PubMed ID: 23334717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryoablation for treatment of cardiac arrhythmias: results of the European Heart Rhythm Association survey.
    Chen J; Lenarczyk R; Boveda S; Richard Tilz R; Hernandez-Madrid A; Ptaszynski P; Pudulis J; Dagres N;
    Europace; 2017 Feb; 19(2):303-307. PubMed ID: 28165525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter defibrillator use for primary prevention in ischaemic and non-ischaemic heart disease-indications in the post-DANISH trial era: results of the European Heart Rhythm Association survey.
    Haugaa KH; Tilz R; Boveda S; Dobreanu D; Sciaraffia E; Mansourati J; Papiashvili G; Dagres N
    Europace; 2017 Apr; 19(4):660-664. PubMed ID: 28431077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement of implantable cardioverter defibrillators and cardiac resynchronization therapy devices: results of the European Heart Rhythm Association survey.
    Tilz R; Boveda S; Deharo JC; Dobreanu D; Haugaa KH; Dagres N
    Europace; 2016 Jun; 18(6):945-9. PubMed ID: 27297231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nationwide survey on the current practice of ventricular tachycardia ablation.
    Vergara P; Casella M; Barbato G; De Ruvo E; Grandinetti G; Notarstefano P; Tola G; Calvi V; Santini L; Nissardi V; Nonis A; Ricci RP; Boriani G; Tondo C; Della Bella P
    J Cardiovasc Med (Hagerstown); 2019 Sep; 20(9):597-605. PubMed ID: 31318839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year outcomes of monomorphic ventricular tachycardia catheter ablation in repaired tetralogy of Fallot.
    Laredo M; Frank R; Waintraub X; Gandjbakhch E; Iserin L; Hascoët S; Himbert C; Gallais Y; Hidden-Lucet F; Duthoit G
    Arch Cardiovasc Dis; 2017 May; 110(5):292-302. PubMed ID: 28347634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%.
    Maury P; Baratto F; Zeppenfeld K; Klein G; Delacretaz E; Sacher F; Pruvot E; Brigadeau F; Rollin A; Andronache M; Maccabelli G; Gawrysiak M; Brenner R; Forclaz A; Schlaepfer J; Lacroix D; Duparc A; Mondoly P; Bouisset F; Delay M; Hocini M; Derval N; Sadoul N; Magnin-Poull I; Klug D; Haïssaguerre M; Jaïs P; Della Bella P; De Chillou C
    Eur Heart J; 2014 Jun; 35(22):1479-85. PubMed ID: 24536081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.
    Al-Khatib SM; Daubert JP; Anstrom KJ; Daoud EG; Gonzalez M; Saba S; Jackson KP; Reece T; Gu J; Pokorney SD; Granger CB; Hess PL; Mark DB; Stevenson WG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):151-7. PubMed ID: 25332150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia: Post-Approval THERMOCOOL VT Trial.
    Marchlinski FE; Haffajee CI; Beshai JF; Dickfeld TL; Gonzalez MD; Hsia HH; Schuger CD; Beckman KJ; Bogun FM; Pollak SJ; Bhandari AK
    J Am Coll Cardiol; 2016 Feb; 67(6):674-683. PubMed ID: 26868693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How are arrhythmias managed in the paediatric population in Europe? Results of the European Heart Rhythm survey.
    Hernández-Madrid A; Hocini M; Chen J; Potpara T; Pison L; Blomström-Lundqvist C;
    Europace; 2014 Dec; 16(12):1852-6. PubMed ID: 25417228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-density substrate-guided ventricular tachycardia ablation: role of activation mapping in an attempt to improve procedural effectiveness.
    Carbucicchio C; Ahmad Raja N; Di Biase L; Volpe V; Dello Russo A; Trivedi C; Bartoletti S; Zucchetti M; Casella M; Russo E; Santangeli P; Moltrasio M; Tundo F; Fassini G; Natale A; Tondo C
    Heart Rhythm; 2013 Dec; 10(12):1850-8. PubMed ID: 24055940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How are arrhythmias detected by implanted cardiac devices managed in Europe? Results of the European Heart Rhythm Association Survey.
    Todd D; Hernandez-Madrid A; Proclemer A; Bongiorni MG; Estner H; Blomström-Lundqvist C;
    Europace; 2015 Sep; 17(9):1449-53. PubMed ID: 26443791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Santangeli P; Zado ES; Supple GE; Haqqani HM; Garcia FC; Tschabrunn CM; Callans DJ; Lin D; Dixit S; Hutchinson MD; Riley MP; Marchlinski FE
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1413-21. PubMed ID: 26546346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
    Potpara TS; Lenarczyk R; Larsen TB; Deharo JC; Chen J; Dagres N;
    Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association.
    Raatikainen MJ; Arnar DO; Merkely B; Camm AJ; Hindricks G
    Europace; 2016 Aug; 18 Suppl 3():iii1-iii79. PubMed ID: 27496955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indications for catheter ablation of ventricular tachycardia].
    Deneke T; Israel CW; Krug J; Nentwich K; Müller P; Mügge A; Schade A
    Dtsch Med Wochenschr; 2013 Sep; 138(39):1952-6. PubMed ID: 24046136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryocure-VT: the safety and effectiveness of ultra-low-temperature cryoablation of monomorphic ventricular tachycardia in patients with ischaemic and non-ischaemic cardiomyopathies.
    Verma A; Essebag V; Neuzil P; Dyrda K; Balt J; Dinov B; Darma A; Arya A; Sacher F; Reddy VY; Boersma L; Grigorov I; De Potter T
    Europace; 2024 Mar; 26(4):. PubMed ID: 38582974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.
    Kuck KH; Schaumann A; Eckardt L; Willems S; Ventura R; Delacrétaz E; Pitschner HF; Kautzner J; Schumacher B; Hansen PS;
    Lancet; 2010 Jan; 375(9708):31-40. PubMed ID: 20109864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.